We are live on ! Find out more
VMD icon

Viemed Healthcare
VMD

149 hedge funds and large institutions have $229M invested in Viemed Healthcare in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 54 increasing their positions, 40 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

158% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 12

35% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 40

29% more capital invested

Capital invested by funds: $177M → $229M (+$52M)

13% more funds holding

Funds holding: 132 → 149 (+17)

1.71% more ownership

Funds ownership: 62.69% → 64.4% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
149
Holders Change
+17
Holders Change %
+12.88%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
31
Increased
54
Reduced
40
Closed
12
Calls
$12K
Puts
–
Net Calls
+$12K
Net Calls Change
+$13K

Top Buyers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$2.99M
2
MC
Martin & Co
Tennessee
+$2.27M
3
Creative Planning
Creative Planning
Kansas
+$1.83M
4
HIM
Hillsdale Investment Management
Ontario, Canada
+$1.66M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.26M

Top Sellers

1
SBH
Segall Bryant & Hamill
Illinois
-$2.15M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.73M
3
PAIM
Punch & Associates Investment Management
Minnesota
-$1.12M
4
SL
Sentinus LLC
Illinois
-$814K
5
Los Angeles Capital Management
Los Angeles Capital Management
California
-$571K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$42.6M -$29.2K -3,514 -0.1%
FCM
2
Forager Capital Management
Alabama
$26M +$333K +40,000 +1%
Goldman Sachs
3
Goldman Sachs
New York
$13.1M -$211K -25,399 -2%
VCM
4
Vanguard Capital Management
Pennsylvania
$12M +$10.8M +1,303,384 New
Ameriprise
5
Ameriprise
Minnesota
$8.27M +$628K +75,506 +9%
NCM
6
Nantahala Capital Management
Connecticut
$8.14M -$405K -48,662 -5%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$7.18M +$26.3K +3,160 +0.4%
State Street
8
State Street
Massachusetts
$6.84M +$564K +67,769 +10%
Arrowstreet Capital
9
Arrowstreet Capital
Massachusetts
$6.55M +$2.99M +358,863 +102%
PAIM
10
Punch & Associates Investment Management
Minnesota
$4.95M -$1.12M -133,999 -20%
First Eagle Investment Management
11
First Eagle Investment Management
New York
$4.88M +$95.7K +11,500 +2%
TAM
12
Tocqueville Asset Management
New York
$4.35M – – –
PAM
13
Panagora Asset Management
Massachusetts
$4.35M +$27.9K +3,357 +0.7%
Renaissance Technologies
14
Renaissance Technologies
New York
$4.07M +$11.7K +1,400 +0.3%
RA
15
Raffles Associates
New York
$3.81M -$33.3K -4,000 -1%
Two Sigma Investments
16
Two Sigma Investments
New York
$3.81M +$1.26M +151,680 +58%
BA
17
Bard Associates
Illinois
$3.13M +$4.97K +597 +0.2%
Morgan Stanley
18
Morgan Stanley
New York
$2.99M +$264K +31,767 +11%
MC
19
Martin & Co
Tennessee
$2.51M +$2.27M +273,001 New
PM
20
Penbrook Management
New York
$2.51M +$7.07K +850 +0.3%
Northern Trust
21
Northern Trust
Illinois
$2.32M +$22.1K +2,652 +1%
VPM
22
Vanguard Portfolio Management
Pennsylvania
$2.24M +$2.02M +243,023 New
VFT
23
Vanguard Fiduciary Trust
Pennsylvania
$2.16M +$1.95M +234,252 New
RHJA
24
Rice Hall James & Associates
California
$2.12M – – –
Creative Planning
25
Creative Planning
Kansas
$2.03M +$1.83M +220,402 New
1
2 3 4 5

VMD Hedge Fund Activity: Q1 2026 in Review

149 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q1 2026, worth a combined $229M — up 29% from $177M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new VMD positions and 12 closed out — a net gain of 19 holders — while 54 added to existing stakes and 40 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $2.99M. The largest seller was Segall Bryant & Hamill, exiting entirely with an estimated $2.15M sold.

  • 149 institutional investors held Viemed Healthcare (VMD) as of Q1 2026, up from 132 in Q4 2025.
  • Funds reported $229M of Viemed Healthcare stock for Q1 2026, up 29% quarter-over-quarter.
  • 31 funds opened new Viemed Healthcare positions in Q1 2026 and 12 closed out, a net change of +19 holders.
  • The largest Viemed Healthcare buyer in Q1 2026 was Arrowstreet Capital, an estimated $2.99M added.
  • The largest Viemed Healthcare seller in Q1 2026 was Segall Bryant & Hamill, an estimated $2.15M sold.

Based on aggregated 13F filings for Q1 2026.